UNSPSC 51262404: Labetalol

This classification denotes an adrenergic antagonist with the molecular formula C19H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R5H8897N95, chemically known as benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)- but generally known as labetalol, which bears US NIH Compound Identifier 3869. European Medicines Agency schedules Labetalol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08382MIG.

UNSPSC 51262404 Labetalol is a Commodity code for a specific pharmaceutical product, but state and local procurement activity under this code shows minimal relevant recent solicitation volume. Labetalol — a beta-blocker antihypertensive medication — is a narrow clinical pharmaceutical line item, and state and local governments acquire it primarily through established health department, corrections, and emergency medical service supply chains rather than through open competitive solicitations.

The single recent opportunity tagged to this code, Seminole County, Florida IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023), solicits Naloxone and Safe Drug Deactivation Systems rather than Labetalol itself, indicating a mismatch between the UNSPSC code assignment and the actual procurement scope. Naloxone is an opioid antagonist used in overdose reversal — a different pharmaceutical category and clinical use case entirely. This mismatch suggests either a data-entry error in the county's procurement system or a broad tagging practice that does not reflect the specific commodity line. No other recent state or local opportunities appear in the dataset under this code. Procurement professionals evaluating this Commodity code should expect sparse RFP, RFQ, or IFB volume and should verify that any opportunities tagged to it are actually seeking Labetalol rather than related but distinct pharmaceuticals, since current activity under the code does not reflect genuine demand for the named product.